Brief: Blinklab Says Two Additional Strategic Partnerships Advance FDA Submission
Aug 26 (Reuters) - BlinkLab Ltd BB1.AX: TWO ADDITIONAL STRATEGIC PARTNERSHIPS ADVANCE FDA SUBMISSION CINCINNATI CHILDREN'S MEDICAL CENTER AND SEATTLE CHILDREN'S RESEARCH INSTITUTE JOIN CO'S FDA TRIAL Further company coverage: BB1.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BlinkLab
See all newsAustralia's BlinkLab hits four-month high on positive ADHD study results
Brief: BlinkLab Seeks Trading Halt
Brief: BlinkLab Partners With Escuela Superior Politécnica De Chimborazo On Large-Scale Ecuador Autism Study
Australia's BlinkLab falls on discounted placement
Brief: Blinklab Secures A$17.5M To Launch Autism Diagnostic Aid